| Identification | Back Directory | [Name]
AMG-208 | [CAS]
1002304-34-8 | [Synonyms]
CS-191
AMG-208
AMG-208, >=98%
AMG208; AMG 208
AMG-208 USP/EP/BP
AMG-208;AMG208; AMG 208
7-Methoxy-4-[(6-phenyl-1,2,4-triazolo[4,3-b]pyridazin-3-yl)methoxy]quinoline
Quinoline, 7-Methoxy-4-[(6-phenyl-1,2,4-triazolo[4,3-b]pyridazin-3-yl)Methoxy]-
7-Methoxy-4-[(6-phenyl-1,2,4-triazolo[4,3-b]pyridazin-3-yl)methoxy]quinoline AMG 208 | [Molecular Formula]
C22H17N5O2 | [MDL Number]
MFCD17215205 | [MOL File]
1002304-34-8.mol | [Molecular Weight]
383.41 |
| Chemical Properties | Back Directory | [density ]
1.34 | [storage temp. ]
Store at -20°C | [solubility ]
insoluble in EtOH; insoluble in H2O; ≥3.83 mg/mL in DMSO | [form ]
solid | [pka]
5.98±0.27(Predicted) |
| Hazard Information | Back Directory | [Definition]
ChEBI: A member of the class of quinolines that is 7-methoxyquinoline substituted at position 4 by a (6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy group. AMG exhibits antitumour activity, particularly in prostate cancer. | [target]
Met |
|
|